Amplify Seymour Cannabis ETF (CNBS)
ARCA ARCA Primary 
Dividend Safety Check: CNBS and Income in the Cannabis Sector
The Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) sits at the awkward intersection of a thematic sector bet and an income wrapper.
CNBS Rallied Triple Digits On One Regulatory Bet, Not Dividends
The Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) has rallied sharply in 2026, with shares up 105% over the past year and 9% in just the last week.
Cannabis ETF (CNBS) Hits New 52-Week High
CNBS Cannabis ETF climbs to a 52-week high, fueled by rescheduling optimism and potential further gains.
6 Top-Performing ETF Areas of Last Week
Cannabis, metals, space and health care led ETF gains last week. WEED, CNBS, SIL, UFO, GDXJ, PLTM and OZEM outperformed despite tech weakness.
5 ETFs to Watch as Restrictions on Marijuana Set to Ease
Cannabis stocks soared on Friday following news that U.S. president Donald Trump is expected to sign an executive order as soon as Monday that would ultimately ease federal restrictions on marijuana. The order would essentially reclassify marijuana from a Schedule I substance to Schedule III under the federal Controlled Substances Act.
3 ETF Categories That Shined in July 2025
July 2025 proved to be a compelling month for ETF investors, marked by a return to risk-on sentiment in some areas of the market, even as broader economic signals remained mixed. U.S. stocks saw a strong 2.2% rally, offsetting a decline in international markets.
CNBS Is A New Opportunity For Cannabis Investors
Amplify's CNBS ETF has shifted focus to American cannabis and hemp, making it a better option than MSOS due to its more diversified structure. CNBS's portfolio is less concentrated in a few stocks compared to MSOS, reducing risk and offering better potential for long-term performance. Risks include 280E taxation remaining, CNBS's smaller size, and limited liquidity, but Tim Seymour's active management is a positive factor.
